Long-Term Protective Effects of Succinate Dehydrogenase Inhibition during Reperfusion with Malonate on Post-Infarction Left Ventricular Scar and Remodeling in Mice.
Laura Valls-LacalleMarta ConsegalFreddy G GanseLaia Yáñez-BisbeJavier PastorMarisol Ruiz-MeanaJavier InserteBegoña BenitoIgnacio Ferreira-GonzálezAntonio Rodriguez-SinovasPublished in: International journal of molecular sciences (2024)
Succinate dehydrogenase inhibition with malonate during initial reperfusion reduces myocardial infarct size in both isolated mouse hearts subjected to global ischemia and in in situ pig hearts subjected to transient coronary ligature. However, the long-term effects of acute malonate treatment are unknown. Here, we investigated whether the protective effects of succinate dehydrogenase inhibition extend to a reduction in scar size and adverse left ventricular remodeling 28 days after myocardial infarction. Initially, ten wild-type mice were subjected to 45 min of left anterior descending coronary artery (LAD) occlusion, followed by 24 h of reperfusion, and were infused during the first 15 min of reperfusion with saline with or without disodium malonate (10 mg/kg/min, 120 μL/kg/min). Malonate-treated mice depicted a significant reduction in infarct size (15.47 ± 3.40% of area at risk vs. 29.34 ± 4.44% in control animals, p < 0.05), assessed using triphenyltetrazolium chloride. Additional animals were then subjected to a 45 min LAD ligature, followed by 28 days of reperfusion. Treatment with a single dose of malonate during the first 15 min of reperfusion induced a significant reduction in scar area, measured using Picrosirius Red staining (11.94 ± 1.70% of left ventricular area (n = 5) vs. 23.25 ± 2.67% (n = 9), p < 0.05), an effect associated with improved ejection fraction 28 days after infarction, as determined using echocardiography, and an attenuated enhancement in expression of the pro-inflammatory and fibrotic markers NF-κB and Smad2/3 in remote myocardium. In conclusion, a reversible inhibition of succinate dehydrogenase with a single dose of malonate at the onset of reperfusion has long-term protective effects in mice subjected to transient coronary occlusion.
Keyphrases
- acute myocardial infarction
- cerebral ischemia
- left ventricular
- aortic stenosis
- wild type
- coronary artery
- subarachnoid hemorrhage
- ejection fraction
- blood brain barrier
- acute ischemic stroke
- brain injury
- percutaneous coronary intervention
- hypertrophic cardiomyopathy
- high fat diet induced
- cardiac resynchronization therapy
- coronary artery disease
- heart failure
- left atrial
- mitral valve
- pulmonary artery
- signaling pathway
- oxidative stress
- cell proliferation
- type diabetes
- acute coronary syndrome
- computed tomography
- pulmonary hypertension
- adipose tissue
- high glucose
- metabolic syndrome
- emergency department
- replacement therapy
- respiratory failure
- acute respiratory distress syndrome
- newly diagnosed
- liver failure
- skeletal muscle
- high resolution
- lps induced
- endothelial cells
- wound healing
- inflammatory response
- bone loss
- hepatitis b virus